BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29059186)

  • 1. Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
    Kar SK; Dwibedi B; Das BK; Agrawala BK; Ramachandran CP; Horton J
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005631. PubMed ID: 29059186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T; Ismid IS; Rückert P; Fischer P
    Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic pathology in Wuchereria bancrofti microfilaraemic infections.
    Dissanayake S; Watawana L; Piessens WF
    Trans R Soc Trop Med Hyg; 1995; 89(5):517-21. PubMed ID: 8560529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
    Shenoy RK; Suma TK; Kumaraswami V; Rahmah N; Dhananjayan G; Padma S
    Ann Trop Med Parasitol; 2009 Apr; 103(3):235-47. PubMed ID: 19341538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
    Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
    J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
    Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
    Rizzo JA; Belo C; Lins R; Dreyer G
    Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis.
    Hussein O; El Setouhy M; Ahmed ES; Kandil AM; Ramzy RM; Helmy H; Weil GJ
    Am J Trop Med Hyg; 2004 Oct; 71(4):471-7. PubMed ID: 15516645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
    Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
    Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 19. An allele specific PCR assay for screening for drug resistance among Wuchereria bancrofti populations in India.
    Hoti SL; Dhamodharan R; Subramaniyan K; Das PK
    Indian J Med Res; 2009 Aug; 130(2):193-9. PubMed ID: 19797818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
    Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.